Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease.

Clinical chemistry - 1 Jul 2007

Dieplinger Benjamin, Lingenhel Arno, Baumgartner Nadja, Poelz Werner, Dieplinger Hans, Haltmayer Meinhard, Kronenberg Florian, Mueller Thomas

Abstract excerpt

BACKGROUND: Increased concentrations of lipoprotein(a) [Lp(a)] have been considered a genetically determined risk factor for coronary artery and cerebrovascular disease. Only 2 small and conflicting studies have investigated the possibility of an association of peripheral arterial disease (PAD) with high serum Lp(a) concentrations and low molecular weight (LMW) phenotypes of apolipoprotein(a) [apo(a)]. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoprotein(a)
Share to Biomarkers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Lipoprotein(a)

Share to Logistic Models

Share to Molecular Weight

Share to Peripheral Vascular Diseases

Source

Identifiers

PMID: 17525104
DOI: 10.1373/clinchem.2007.088013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease.PMID 17525104Read ↗

Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts.Semantic proximity Read ↗

Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations.Semantic proximity Read ↗

Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – Some answers and still many questionsSemantic proximity Read ↗

Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC).Semantic proximity Read ↗

Lipid-associated GWAS loci as important markers of the risk, severity, and clinical course of peripheral artery disease.Semantic proximity Read ↗

Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus.Semantic proximity Read ↗

Lipoprotein(a) and cardiovascular disease in diabetic patientsSemantic proximity Read ↗

Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk.Semantic proximity Read ↗

Apolipoprotein(a) and thrombosis: molecular and genetic bases of hyper-lipoprotein(a)-emia.Semantic proximity Read ↗

Studies on apolipoprotein(a) phenotypes. Part 2. Phenotype frequencies and Lp(a) concentrations in different phenotypes in patients with angiographically defined coronary artery diseases.Semantic proximity Read ↗

[Association of lipoprotein(a) and apolipoprotein(a) phenotypes with coronary and carotid atherosclerosis in CHD men].Semantic proximity Read ↗

Lipoprotein(a). A genetic risk factor for premature coronary heart diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.